Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: A laser capture microdissection study of 15 cases

Histopathology

Volumn 47, Issue 6, 2005, Pages 582-586

  Henley, John D ^a,c   Summerlin, D J ^b   Tomich, C ^b   Zhang, S ^a   Cheng, L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^c NONE   (United States)

Author keywords

Clonality; Laser capture; Loss of heterozygosity; Microdissection; Odontogenic keratocyst

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; ODONTOGENIC KERATOCYST; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ALLELES; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; GENE FREQUENCY; GENETIC MARKERS; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MANDIBULAR DISEASES; MAXILLARY DISEASES; MICRODISSECTION; ODONTOGENIC CYSTS;

EID: 28844482638     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02267.x     Document Type: Article

References (36)

1. Blanas N, Freund B, Schwartz M, Furst IM. Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2000; 90; 553-558.
2. Meara JG, Shah S, Li KK, Cunningham MJ. The odontogenic keratocyst: a 20-year clinicopathologic review. Laryngoscope 1998; 108; 280-283.
3. World Health Organization. Histological typing of odontogenic tumours. In International histological classification of tumours, 2nd edn. Berlin: Springer-Verlag 1991.
4. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol. 2002; 38; 323-331.
5. Li TJ, Browne RM, Matthews JB. Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. J. Oral Pathol. Med. 1994; 23; 184-189.
6. Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J. Oral Pathol. Med. 1995; 24; 393-397.
7. Piattelli A, Fioroni M, Santinelli A, Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol. 1998; 34; 408-412.
8. Ogden GR, Chisholm DM, Kiddie RA, Lane DP. p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J. Clin. Pathol. 1992; 45; 1007-1010.
9. Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J. Oral Pathol. Med. 1996; 25; 249-255.
10. Piattelli A, Fioroni M, Santinelli A, Rubini C. P53 protein expression in odontogenic cysts. J. Endod. 2001; 27; 459-461.
11. Lench NJ, High AS, Markham AF, Hume WJ, Robinson PA. Investigation of chromosome 9q22.3-q31 DNA marker loss in odontogenic keratocysts. Eur. J. Cancer B Oral Oncol. 1996; 32B; 202-206.
12. Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L. PTCH gene mutations in odontogenic keratocysts. J. Dent. Res. 2000; 79; 1418-1422.
13. Nawshad AI, Savage NW, Young WG, Smyth I, Wicking C. Allelic losses in chromosome 9q22.3-31q in odontogenic keratocysts. J. Oral Pathol. Med. 2000; 29 (Abstract 44); 353.
14. Agaram NP, Collins BM, Barnes L et al. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch. Pathol. Lab. Med. 2004; 128; 313-317.
15. Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J. Clin. Oncol. 1999; 17; 1618-1624.
16. Gotte K, Hadaczek P, Coy JF et al. Fhit expression is absent or reduced in a subset of primary head and neck cancer. Anticancer Res. 2000; 20; 1057-1060.
17. Tanimoto K, Hayashi S, Tsuchiya E et al. Abnormalities of the FHIT gene in human oral carcinogenesis. Br. J. Cancer 2000; 82; 838-843.
18. Jang SJ, Chiba I, Hirai A, Hong WK, Mao L. Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 2001; 20; 2235-2242.
19. Prime SS, Eveson JW, Guest PG, Parkinson EK, Paterson IC. Early genetic and functional events in the pathogenesis of oral cancer. Radiat. Oncol. Invest. 1997; 5; 93-96.
20. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int. J. Cancer 1999; 83; 318-25.
21. Kresty LA, Mallery SR, Knobloch TJ et al. Alterations of p16 (INK4a) and p14 (ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002; 62; 5295-5300.
22. Sanz-Ortega J, Valor C, Saez MC et al. 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol. Histopathol. 2003; 18; 1053-1057.
23. Gebhart E, Liehr T, Wolff E, Wiltfang J, Koscielny S, Ries J. Loss of 9p21 is embedded in a complex but consistent pattern of genomic imbalances in oral squamous cell carcinomas. Cytogenet. Genome Res. 2003; 101; 106-112.
24. Ito T, Shimada Y, Hashimoto Y et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res. 2003; 63; 6320-6326.
25. Lazar AD, Winter MR, Nogueira CP et al. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin. Cancer Res. 1998; 4; 2787-2793.
26. Yen CC, Chen YJ, Chen JT et al. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001; 92; 2769-2777.
27. Ishizaki K, Fujimoto J, Kumimoto H et al. Frequent polymorphic changes but rare tumor specific mutations of the LATS2 gene on 13q11-12 in esophageal squamous cell carcinoma. Int. J. Oncol. 2002; 21; 1053-1057.
28. Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture microdissection. Science 1996; 274; 998-1001.
29. Bonner RF, Emmert-Buck M, Cole K et al. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278 (1481); 1483.
30. Paradiso A, Ranieri G, Stea B et al. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Int. J. Oncol. 2004; 24; 249-255.
31. Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res. 1998; 58; 389-391.
32. Cheng L, Song SY, Pretlow TG et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J. Natl Cancer Inst. 1998; 90; 233-237.
33. Cheng L, Gu J, Eble JN et al. Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas. Am. J. Surg. Pathol. 2001; 25; 1231-1236.
34. Cheng L, Bostwick DG, Li G et al. Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 1999; 85; 2017-2022.
35. Gu J, Roth LM, Younger C et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J. Natl Cancer Inst. 2001; 93; 1147-1152.
36. Makowski GJ, McGuff S, Van Sickels JE. Squamous cell carcinoma in a maxillary odontogenic keratocyst. J. Oral Maxillofac. Surg. 2001; 59; 76-80.